Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Florian Stroie

Urology Tampa, FL Doctor of Osteopathy

NPI 1699295808 CMS profile 3399768

2 Tampa General Cir, Tampa, FL 33606

Open in the dashboard

General payments

$18,194

161 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Florian Stroie of Tampa, FL is reported in the CMS Open Payments database as having received $18,194 across 161 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,208 13
2024 General $703 5
2023 General $6,893 65
2022 General $8,096 70
2021 General $67 2
2019 General $226 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Florian Stroie
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Florian Stroie were reported at $2,208. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Florian Stroie Urology median Middle half National median
2019 $226 $480 $147–$1,201 $163
2020 $0 $246 $87–$645 $114
2021 $67 $358 $111–$1,000 $132
2022 $8,096 $476 $143–$1,263 $149
2023 $6,893 $560 $168–$1,461 $160
2024 $703 $563 $170–$1,464 $164
2025 $2,208 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Coloplast Corp $9,577 91 payments
  2. Boston Scientific Corporation $7,526 58 payments
  3. Rigicon,Inc. $748 3 payments
  4. Antares Pharma, Inc. $100 2 payments
  5. Endo Pharmaceuticals Inc. $77 2 payments
  6. Acerus Pharmaceuticals Corporation $76 1 payment
  7. Organogenesis Inc. $49 2 payments
  8. Axonics Modulation Technologies, Inc. $24 1 payment
  9. Dentsply Ih AB $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $9,988 48 payments
  2. Food and Beverage $7,755 111 payments
  3. Education $280 1 payment
  4. Consulting Fee $170 1 payment
Products named General payments · program years 2019–2025
  1. Titan $9,078 87 payments
  2. AMS 700 CXR RTE Kit $3,133 19 payments
  3. General - Therapies $2,056 10 payments
  4. AdVance XP $705 3 payments
  5. RIGI10 MALLEABLE PENILE PROSTHESIS Erectile Dysfunction $581 2 payments
  6. AMS 700 $421 4 payments
  7. TACTRA $333 5 payments
  8. Altis $320 2 payments
  9. General - Erectile Dysfunction $280 3 payments
  10. Rigi10 Malleable Penile Prosthesis Penile Implants $166 1 payment
  11. Other $942 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$8,671

Medicare's payments for the services billed

Medicare patients

45

Average age 70

Services billed

87

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 49%
Heart failure 40%
Ischemic heart disease 38%
Chronic kidney disease 36%
COPD 36%
Cancer 31%
Arthritis 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

161 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record